Chemotherapy-induced peripheral neuropathy assessment tools: A systematic review

Haryani Haryani, Susan Jane Fetzer, Ching Lin Wu, Yu Yun Hsu

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Problem Identification: Chemotherapy-induced peripheral neuropathy (CIPN) is a doselimiting chemotherapy toxicity, which has a long-lasting effect and decreases quality of life. Although several tools have been developed to detect CIPN, the study quality, psychometric properties, and practicality of CIPN assessment tools have not been systematically reviewed. Literature Search: Electronic searches using keywords were conducted in Medline, PubMed, CINAHL®, and Cochrane Library for articles published from 1980-2015. Eligible studies were included if they involved patients with cancer receiving chemotherapy, provided CIPN assessment tools with psychometric properties, and were published in English. Data Evaluation: Data were extracted, and study quality was assessed. CIPN tools were evaluated in terms of psychometric properties and practicality. Synthesis: A total of 19 studies describing 20 tools were reviewed. The quality of studies varied from strong to weak. The validity ranged from low to high, and the reliability with internal consistency ranged from 0.56-0.96. Poor inter-rater agreement was found. Not all of the tools were deemed practical. Conclusions: Considering the psychometric properties and practicality, two tools (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [FACT/GOG-Ntx] and Total Neuropathy Score [TNS]) are recommended for assessing CIPN. Implications for Nursing: Routine assessment of CIPN and choosing appropriate assessment tools are imperative. The FACT/GOG-Ntx and TNS are recommended for clinical use.

Original languageEnglish
Pages (from-to)E111-E123
JournalOncology Nursing Forum
Volume44
Issue number3
DOIs
Publication statusPublished - 2017 May

Fingerprint

Peripheral Nervous System Diseases
Drug Therapy
Psychometrics
Nursing Assessment
Neoplasms
PubMed
Libraries
Quality of Life
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology(nursing)

Cite this

Haryani, Haryani ; Fetzer, Susan Jane ; Wu, Ching Lin ; Hsu, Yu Yun. / Chemotherapy-induced peripheral neuropathy assessment tools : A systematic review. In: Oncology Nursing Forum. 2017 ; Vol. 44, No. 3. pp. E111-E123.
@article{2a976d987a5646a8b5f4c8e24cb1df03,
title = "Chemotherapy-induced peripheral neuropathy assessment tools: A systematic review",
abstract = "Problem Identification: Chemotherapy-induced peripheral neuropathy (CIPN) is a doselimiting chemotherapy toxicity, which has a long-lasting effect and decreases quality of life. Although several tools have been developed to detect CIPN, the study quality, psychometric properties, and practicality of CIPN assessment tools have not been systematically reviewed. Literature Search: Electronic searches using keywords were conducted in Medline, PubMed, CINAHL{\circledR}, and Cochrane Library for articles published from 1980-2015. Eligible studies were included if they involved patients with cancer receiving chemotherapy, provided CIPN assessment tools with psychometric properties, and were published in English. Data Evaluation: Data were extracted, and study quality was assessed. CIPN tools were evaluated in terms of psychometric properties and practicality. Synthesis: A total of 19 studies describing 20 tools were reviewed. The quality of studies varied from strong to weak. The validity ranged from low to high, and the reliability with internal consistency ranged from 0.56-0.96. Poor inter-rater agreement was found. Not all of the tools were deemed practical. Conclusions: Considering the psychometric properties and practicality, two tools (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [FACT/GOG-Ntx] and Total Neuropathy Score [TNS]) are recommended for assessing CIPN. Implications for Nursing: Routine assessment of CIPN and choosing appropriate assessment tools are imperative. The FACT/GOG-Ntx and TNS are recommended for clinical use.",
author = "Haryani Haryani and Fetzer, {Susan Jane} and Wu, {Ching Lin} and Hsu, {Yu Yun}",
year = "2017",
month = "5",
doi = "10.1188/17.ONF.E111-E123",
language = "English",
volume = "44",
pages = "E111--E123",
journal = "Oncology Nursing Forum",
issn = "0190-535X",
publisher = "Oncology Nursing Society",
number = "3",

}

Chemotherapy-induced peripheral neuropathy assessment tools : A systematic review. / Haryani, Haryani; Fetzer, Susan Jane; Wu, Ching Lin; Hsu, Yu Yun.

In: Oncology Nursing Forum, Vol. 44, No. 3, 05.2017, p. E111-E123.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Chemotherapy-induced peripheral neuropathy assessment tools

T2 - A systematic review

AU - Haryani, Haryani

AU - Fetzer, Susan Jane

AU - Wu, Ching Lin

AU - Hsu, Yu Yun

PY - 2017/5

Y1 - 2017/5

N2 - Problem Identification: Chemotherapy-induced peripheral neuropathy (CIPN) is a doselimiting chemotherapy toxicity, which has a long-lasting effect and decreases quality of life. Although several tools have been developed to detect CIPN, the study quality, psychometric properties, and practicality of CIPN assessment tools have not been systematically reviewed. Literature Search: Electronic searches using keywords were conducted in Medline, PubMed, CINAHL®, and Cochrane Library for articles published from 1980-2015. Eligible studies were included if they involved patients with cancer receiving chemotherapy, provided CIPN assessment tools with psychometric properties, and were published in English. Data Evaluation: Data were extracted, and study quality was assessed. CIPN tools were evaluated in terms of psychometric properties and practicality. Synthesis: A total of 19 studies describing 20 tools were reviewed. The quality of studies varied from strong to weak. The validity ranged from low to high, and the reliability with internal consistency ranged from 0.56-0.96. Poor inter-rater agreement was found. Not all of the tools were deemed practical. Conclusions: Considering the psychometric properties and practicality, two tools (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [FACT/GOG-Ntx] and Total Neuropathy Score [TNS]) are recommended for assessing CIPN. Implications for Nursing: Routine assessment of CIPN and choosing appropriate assessment tools are imperative. The FACT/GOG-Ntx and TNS are recommended for clinical use.

AB - Problem Identification: Chemotherapy-induced peripheral neuropathy (CIPN) is a doselimiting chemotherapy toxicity, which has a long-lasting effect and decreases quality of life. Although several tools have been developed to detect CIPN, the study quality, psychometric properties, and practicality of CIPN assessment tools have not been systematically reviewed. Literature Search: Electronic searches using keywords were conducted in Medline, PubMed, CINAHL®, and Cochrane Library for articles published from 1980-2015. Eligible studies were included if they involved patients with cancer receiving chemotherapy, provided CIPN assessment tools with psychometric properties, and were published in English. Data Evaluation: Data were extracted, and study quality was assessed. CIPN tools were evaluated in terms of psychometric properties and practicality. Synthesis: A total of 19 studies describing 20 tools were reviewed. The quality of studies varied from strong to weak. The validity ranged from low to high, and the reliability with internal consistency ranged from 0.56-0.96. Poor inter-rater agreement was found. Not all of the tools were deemed practical. Conclusions: Considering the psychometric properties and practicality, two tools (Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity [FACT/GOG-Ntx] and Total Neuropathy Score [TNS]) are recommended for assessing CIPN. Implications for Nursing: Routine assessment of CIPN and choosing appropriate assessment tools are imperative. The FACT/GOG-Ntx and TNS are recommended for clinical use.

UR - http://www.scopus.com/inward/record.url?scp=85018372032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018372032&partnerID=8YFLogxK

U2 - 10.1188/17.ONF.E111-E123

DO - 10.1188/17.ONF.E111-E123

M3 - Review article

C2 - 28635977

AN - SCOPUS:85018372032

VL - 44

SP - E111-E123

JO - Oncology Nursing Forum

JF - Oncology Nursing Forum

SN - 0190-535X

IS - 3

ER -